Cell Therapy News/Articles, page-17674

Thanks for sharing@Wilba32

I think it important to also reference Dr Lightner's response to Dr Cheng's letter to the editor re the important role of anti-TNF in treating refractory pCD, suggesting a contributing role of MSCs....

From Dr Lightner's reply
"however, by definition, the patients enrolled were refractory to anti-TNF, and their fistulas had not healed despite being on medical therapy. In fact, all patients enrolled had either failed medical therapy or were on stable medical therapy for at least 3 months before study enrollment to minimize any
confounding with MSC healing."

Good signs but more work to do

DYOR

V




Reference: